Incinerator solutions for the pharmaceutical sector - Chemical & Pharmaceuticals - Pharmaceutical
Pharmaceuticals are now shown to be found in surface, ground, and drinking waters around the world. This could create some potentially damaging environmental effects. Minuscule concentrations of chemicals known as endocrine disruptors, often found in pharmaceuticals, are having detrimental effects on aquatic animals and possibly on human health and development.
-
Most popular related searches
Applications Overview
Sources of Pharmaceutical Waste
- pharmaceutical manufacturers
- laboratories and research centres
- chemists and dispensaries
- nursing homes for the elderly
- humanitarian organisations
Why Incinerate Medicines?Incineration in specialised medical incinerators is the recommended process suggested by most health and monitoring organisations (e.g. WHO, DEA, UN). It is seen as the best way to destroy intravenous (IV) preparations, partially used vials, syringes, and IVs, discontinued, unused preparations, unused unit dose repacks, patients’ personal medications and outdated pharmaceuticals All waste should be segregated appropriately BEFORE it is incinerated to ensure you comply to local guidelines.What is considered hazardous waste?
Frequently used pharmaceuticals, such as physostigmine, warfarin, and nine chemotherapeutic agents (see below), are regulated as hazardous waste in most countries and bottom ash should be disposed into a recognised hazardous waste facility.
Trace Chemotherapy Agents
- Trisenox
- Leukeran
- Cytoxan, Neosar
- Daunorubicin, Cerubidin, DaunoXome, Rubidomycin
- DES, Stilphostrol
- Alkeran, L-PAM
- Mitomycin, Mutamycin
- Streptozocin, Zanosar
- Uracil Mustard
Incineration is still seen as the preferred process for the safe destruction of these materials.
